Prot# GS-US-228-0101: A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults with Non-Alcoholic Steatohepatitis (NASH)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/14/091/14/12

Funding

  • PPD Development (GS-US-228-0101)
  • Gilead Sciences, Inc. (GS-US-228-0101)